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Fluorescence microscopy imaging enables receptor proteins to
be investigated within their biological context. A key challenge
is to site-specifically incorporate reporter moieties into proteins
without interfering with biological functions or cellular net-
works. Small peptide tags offer the opportunity to combine
inducible labeling with small tag sizes that avoid receptor
perturbation. Herein, we review the current state of live-cell
labeling of peptide-tagged cell-surface proteins. Considering
their importance as targets in medicinal chemistry, we focus on
membrane receptors such as G protein-coupled receptors
(GPCRs) and receptor tyrosine kinases (RTKs). We discuss
peptide tags that i) are subject to enzyme-mediated modifica-
tion reactions, ii) guide the complementation of reporter
proteins, iii) form coiled-coil complexes, and iv) interact with
metal complexes. Given our own contributions in the field, we
place emphasis on peptide-templated labeling chemistry.
1. Introduction
In order to survive, eukaryotic cells need to adapt to environ-
mental changes. For this purpose, receptor proteins in the cell
membrane convert extracellular stimuli into intracellular signal
responses. Three important families of membrane receptors
encoded in the human genome are G protein-coupled
receptors (GPCR), receptor tyrosine kinases (RTK) and ligand-
controlled ion channels. Herein, we will focus on the former
two families. The GPCRs are the largest family of membrane
receptors which are characterized by a common architecture
with a transmembrane helix bundle, an extracellular N terminus
and an intracellular C terminus.[1] GPCR ligands are diverse
ranging from ions and small molecules to peptides and
proteins.[2] Ligand binding to GPCRs induces the stabilization of
distinct conformations, leading to the activation of G proteins
and the generation of intracellular second messengers like Ca2+
or cyclic adenosine monophosphate (cAMP).[3,4] To terminate
GPCR signaling, receptors are phosphorylated and translocated
into cytoplasmic compartments.[5,6] Internalized GPCRs are
subsequently transported back to the cell membrane or
degraded in lysosomes.[7] RTKs comprise a single-pass trans-
membrane domain with an extracellular N terminus, containing
the ligand interaction motifs, and an intracellular C terminus,
necessary for activation by phosphorylation.[8] Upon ligand
binding to RTKs, the C-terminal phosphorylation motifs are
exposed and cross-phosphorylated in RTK dimers/oligomers by
an intramolecular kinase domain.[9,10] RTK signaling is propa-
gated by multiple intracellular steps, for example, phosphor-
ylation-dependent activation of Ras proteins or transcription
factors like signal transducer and activator of transcription
(STAT) proteins.[11–15] RTK signaling can be terminated upon
translocation from the cell membrane into cytoplasmic
vesicles.[16] As phosphorylation of the RTK is essential for
activation, phosphatases control RTK signaling by removal of
the phosphate groups.[17] Similar to GPCRs, RTKs can recycle
back to the cell membrane or are degraded with their ligand in
lysosomal compartments.[18,19]
Mechanistic studies of receptor function call for methods
that provide information about their localization, trafficking and
interactions within the native environment. Live cell
fluorescence microscopy has contributed significantly to our
current knowledge. This method requires fluorescent reporter
groups that do not perturb receptor function. Immunochemis-
try allows attachment of reporter groups by means of antibody
binding. However, only a small number of selective antibodies
against membrane-embedded GPCRs and RTKs are commer-
cially available.[20,21] To extend the scope of immunostaining,
also to nanobodies, exogenous peptide antigens such as the
FLAG-tag,[22] HA-tag,[23] V5-tag,[24] ALFA-tag,[25] or BC2-tag[26] are
fused to the protein of interest (POI) N terminus. Common
labeling protocols containing different blocking steps, long
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staining periods, and multiple washing steps exclude immunos-
taining from being applied to the analysis of short-lived
changes in receptor signal transduction in live cells.[27,28]
Furthermore, the large size of antibodies is problematic for the
live cell analysis of proximity-dependent processes. Labeling
with nanobodies can provide a solution to the size problem.[25,26]
It has to be considered that cell fixation and permeabilization
can cause artefacts.[29]
An established approach to visualize cellular proteins relies
on the genetically encoded fusion of the POI with an auto-
fluorescent protein. Since their discovery, fluorescent proteins
(FP) such as the green FP (GFP) have been widely used to
elucidate membrane expression and intracellular trafficking
routes. Although easily implemented, the size of the FPs can
perturb protein function and localization.[30–34] In rare cases,
overexpression of FPs can induce apoptosis.[35] Furthermore, the
maturation of the chromophore creates equivalent amounts of
hydrogen peroxide as by-product.[36,37] The analysis of mem-
brane receptors can be plagued by background from intra-
cellularly retained protein subpopulations due to aggregation
of the FP.[38,39] Methods that allow the introduction of reporter
groups at specified time points can limit label-induced
perturbations. The use of labeling agents that act on the cell
surface also provides a solution to background issues. For
example, self-modifying enzyme tags such as the Halo- and
SNAP-tag have been used to validate membrane localization
and identify novel receptor ligands.[40–46] Enzyme-based tags
with peroxidase activity such as APEX[47] or APEX2[48] use H2O2 to
generate fluorescent signals. Enzymatic catalysis provides for
high sensitivity. Of note, APEX-type tags convert diaminobenzi-
dine to a polymeric material that can be stained with osmium
substrates. This enables imaging by electron microscopy.
Enzyme tags have a molecular weight comparable to FPs (GFP:
27 kDa; Halo-tag: 33 kDa; SNAP-tag: 20 kDa; APEX2: 28 kDa).
Often, the label approaches the size of the POI, potentially
hindering proximity-dependent interactions and limiting the
imaging resolution.
In recent years, powerful methods have been developed
that allow live cell labeling with genetically encoded peptide
tags smaller than 50 amino acids (aa). Such short, encodable
tags display various advantages in comparison to auto-
fluorescent reporters and enzyme tags. Owing to their small
size it is less likely that localization and proximity-dependent
protein interactions are perturbed. Furthermore, a smaller cargo
offers the prospect of a more fine-grained imaging than
possible with enzyme-sized labels. Common to all methods
based on fusion proteins is that the respective POI is provided
by eukaryotic expression vectors under the control of a
promoter sequence. By choosing a suitable promoter sequence,
the translation strength is tunable and allows to control protein
expression levels.[49] Furthermore, different promoters have
been developed to enable inducible expression in mammalian
cells.[50] As encoded peptide tags do not contain a reporter in
themselves, they provide for unrestricted experimental applica-
tion as the reporter can be individually chosen for the desired
assay readout. Additionally, inducible labeling facilitates high
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spatial and temporal resolution of protein behavior in response
to extracellular stimuli. Complementing and updating reviews
on protein fluorescence imaging,[51–56] we focus in this review
on techniques used for live cell analysis of GPCRs and RTKs
based on genetically encoded, small peptide tags.
2. Visualization of Receptor Proteins on the
Surfaces of Live Cells
For successful labeling of membrane proteins, accessibility on
the cell surface is required. The protein needs to be correctly
embedded in the cell membrane without impairing the tightly
regulated intracellular transport.[57–59] Thus, confirming cell-sur-
face expression is a vital part in characterizing tagged
membrane proteins. As the membrane of mammalian cells
poses a natural barrier for compound uptake into the cell,
intracellular labeling is complicated. However, this is advanta-
geous for excluding intracellularly localized receptors from
labeling and facilitates the analysis/tracking of membrane-
embedded receptors.
2.1. Overview of genetically encoded peptide tags for
receptor visualization on live-cell surfaces
Short peptide tags (<50 aa) fused to the N terminus of GPCRs
or RTKs are readily accessible for labeling reagents without
interfering with ligand/receptor interactions. Different techni-
ques have been developed over the years, which visualize
GPCRs and RTKs in live cell experiments. A short summary of
commonly applied N-terminal tags discussed in this review is
provided in Table 1.
2.2. Recognition peptides for chemoenzymatic labeling on
cell membranes
Various enzymes recognize specific peptide sequences and
install posttranslational modifications. Some classes of enzymes
have been successfully applied in labeling of human membrane
proteins. Biotin ligase (BirA), derived from Escherichia coli, allows
the site-specific transfer of biotin to the side chain of a lysine
residue within the recognition sequence of the acceptor
peptide, the AP-tag (GLNDIFEAQKIEWHE; Figure 1B).[60] A two-
step protocol is required for fluorescent protein labeling: firstly,
Table 1. Commonly used methodologies and peptide tag sequences for labeling of membrane-embedded proteins like G protein-coupled receptors and
receptor tyrosine kinases in live mammalian cell systems.
Labeling approach Tag sequence Labeling conditions for live cell application
Biotin ligase[60] GLNDIFEAQKIEWHE (AP-tag) Biotinylation: 0.5 μM BirA, 10 μM biotin and 2 mM ATP in PBS
(reaction time: 20 min at room temperature).[61]
Biotin detection requires reporter-equipped streptavidin.
Ketone probe: 0.2 μM BirA, 1 mM ketone probe, and 1 mM ATP in DPBS
(reaction time: 10–60 min at 32 °C). Subsequent ketone conversion requires
1 mM hydrazine probe (e.g., incubation for 10–60 min at 16 °C).[62]
Lipoic acid ligase[63,64] DEVLVEIETDKAVLEVPGGEEE (LAP-tag)
GFEIDKVWYDLDA (LAP2-tag)
High concentrations of enzyme (10 μM LplA) and lipoic acid derivative (350 μM
azide substrate) and additional co-factors (1 mM ATP) required for labeling within






Labeling is performed within 30 min, using 5 μM CoA substrate, 1 μM enzyme,




Micromolar concentrations of the enzyme (~1 μM) and the labeling agent
(04–0.5 mM) in the presence of 12 mM CaCl2
(reaction time: ~30 min at 4 or 37 °C).[72]
Transpeptidation by
sortase A[73–78]
LPETGGn (n depending on the POI) For protein labeling in live cells: 30 μM SrtA and 10 μM labeling agent (reaction
time up to 1 h at 37 °C).[75]
Tubulin tyrosine
ligase[79]
VDSVEGEGEEEGEE (Tub-tag) For protein modification, 1 μM tubulin tyrosine ligase, 1 mM tyrosine derivative,
and 2.5 mM ATP (reaction time 1–3 h).[79] Subsequent reporter transfer onto the
reactive handle depends on the bio-orthogonal chemistry.
splitNluc
complementation[80]
VSGWRLFKKIS (HiBiT-tag) Luminophore reassembly: addition of 10 nM LgBiT (15 min at 37 °C) prior to
luminescence readout after furimazine addition.[81]
splitGFP reassembly[82] NHYLSTQTVLSKDPNEKRDHMVLHEYVNAAGIT
(GFP10-11; shown without flanking Gly4)
Reporter reassembly: 2 μM of GFP 1–9 (reaction time: 20 min at 37 °C in PBS).[82]
SpyTag/SpyCatcher[83] AHIVMVDAYKPTK 5 μM SpyCatcher-Alexa Fluor 555 in PBS, supplemented with 5 mM Mg2+








Extracellular labeling: incubation with 5 mM MES and 0.5 mM TCEP
(for 20–30 min) prior to addition of FlAsH reactant (2–5 μM).[92]
Ni2+ loaded NTA[94,95] His6 or His10 15 nM of dye-conjugated, Ni
2+-loaded NTA for noncovalent labeling in
<15 min.[96]
Covalent modification: pre-incubation with 0.5 mM TCEP prior to addition
of the labeling probe (0.5 μM) at room temperature.[95]
Split intein[97] Gp41-1 system: N-intein, 88 aa; C-intein,
37 aa
For live cell labeling: 0.5 μM of N-intein, equipped with biotin, and 20 mM
reduced glutathione (reaction time: 8 h).[98]
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on-surface biotinylation of the POI by BirA, followed by biotin
recognition by streptavidin (carrying the desired reporter). As
shown for the Na-K-2Cl cotransporter, protein biotinylation is
efficiently performed within 20 min at room temperature, but
requires micromolar concentrations of enzyme and substrate
(e.g., 0.5 μM biotin ligase and 10 μM biotin) as well as wash
steps to remove excess biotinylation agent.[61] Beyond imaging,
biotin ligase methods have proven invaluable for proximity
ligation assays. Fusion of the biotinylation target sequence, the
AP-tag, and BirA, the biotinylating enzyme, to different POI
enables proximity induced biotinylation for investigation of
protein homo- and heterodimerization. This approach was used
to study the dimerization behavior of the C-X-C motif chemo-
kine receptor 4 (CXCR4), a rhodopsin-like GPCR. For proximity
induced biotinylation, the AP-CXCR4 and BirA-CXCR4 were co-
expressed. Only upon close vicinity of the two GPCR species in
a homodimer, biotinylation of AP-CXCR4 occurs. Since BirA
displays a high affinity towards its substrates (e.g., KD(biotin)
~45 nM),[99] a shortened AP’-tag was exploited to exclude the
BirA/AP-interaction as driving force for GPCR dimerization.[100,101]
The removal of only three residues in the AP sequence lead to a
Km increase from 5 μM to ~345 mM.
[101] Investigations with this
system suggested that the GPCRs exist as a homodimer in the
membrane of live cells. In addition, CXCR4 heterodimerization
with the chemokine receptors 2 and 5 (CCR2/5) was revealed by
this approach.[100] Proximity-based biotinylation of the GPCR
was performed efficiently in 15 min at 100 μM biotin and 1 mM
ATP. Amongst the most prominent BirA mutants used for
proximity assays are BioID (R118G mutation),[102] TurboID[103] (15
mutations), and miniTurbo (N-terminal truncation and 13
mutations)[103]. Not only the enzyme and its target sequence
have been optimized for BirA labeling. To reduce the cargo
added upon visualization of biotinylated proteins with strepta-
vidin (monomeric streptavidin: ~17 kDa), Chen, et al. reported
on a ketone analog of biotin, compatible with BirA labeling,
which allows selective modification of the ketone by hydrazide-
and hydroxylamine-equipped reporter as shown for the
epidermal growth factor receptor (EGFR).[62] To increase rates,
the reactions were performed at slightly acidic pH 6.2.
Lipoic acid ligase (LplA) site-specifically ligates lipoic acid to
a lysine residue of the extracellularly exposed acceptor peptide
LAP (DEVLVEIETDKAVLEVPGGEEE) or its optimized shorter
variant LAP2 (GFEIDKVWYDLDA; Figure 1C).[63,64] This enzyme
recognizes various lipoic acid derivatives as substrate for the
modification of membrane POI. Azide handles allowed subse-
quent fluorescent labeling by azide-alkyne cycloaddition. Other
chemical handles have been introduced to allow second step
labeling via inverse-electron demand Diels-Alder reaction or
tetrazine ligation.[104,105] Engineered LplA variants allowed label-
ing of proteins with coumarin[106] or red-emitting resorufin.[107]
Similar to BirA reaction conditions, LplA requires high concen-
trations of both enzyme and substrate (e.g., 10 μM LplA,
350 μM azide substrate) and addition of a co-factor (1 mM ATP)
for efficient labeling within 1 h incubation time.[63] Due to the
similarity in reaction conditions of LplA and BirA, and the
orthogonality of the peptide tags, the two enzymatic labeling
platforms can be simultaneously combined for dual labeling of
Figure 1. Covalent enzymatic labeling of recognition tags at the N terminus
of live cells. A protein of interest (POI, gray box) tagged with a peptide
recognition tag (green) at the N terminus is selectively labeled with a cargo
(red star) by employing an enzymatically (blue) catalyzed reaction (A).
Enzymatic labeling methodologies: Biotin ligase (BirA, B), lipoic acid ligase
(LplA, C), phosphopantetheinyl transferase (PPTase, D), transglutaminase
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different protein species as demonstrated for AP-tagged EGFR
and LAP-carrying low-density lipoprotein receptor (LAP-LDLR) in
live HEK293 (human embryonic kidney) cells.[63]
Covalent labeling at N-terminal tags can also be achieved
by transferases like the phosphopantetheinyl transferase
(PPTase; Figure 1D). This enzyme transfers 4‘-phosphopante-
theine from coenzyme A (CoA) onto a serine residue of the
recognition sequence.[65] The use of PPTases from different
species, for example, the Sfp enzyme from Bacillus subtilis and
the AcpS enzyme from E. coli allows orthogonal dual
labeling.[66,67] Sfp recognizes the ybbR-tag (DSLEFIASKLA) and
S6-tag (GDSLSWLLRLLN), whereas AcpS targets the A1-tag
(GDSLDMLEWSLM). Transfer of the reporter moiety from CoA to
the POI has been achieved within 30 min by applying 5 μM CoA
substrate and 1 μM enzyme in the presence of high amounts of
cations (e.g., 10 μM Mg2+).[65,68] PPTase-induced live cell labeling
has been applied to the imaging of the human epidermal
growth factor 2 (HER2), EGFR, and the neurokinin-1 receptor
(NK1R).
[68,69,108] A recent study suggests that CoA-dye conjugates
can enter the cell interior and induce modification of
endogenous proteins.[68]
Transglutaminase (TGase) catalyzes the condensation be-
tween the side chains of lysine and glutamine residues. The
genetically encodable tags Q1 (PNPQLPF), Q2 (PKPQQFM), and
Q3 (GQQQLG) present glutamine for conjugation with labeling
reagents based on cadaverine (1,5-diaminopentan) or spermine,
a polyamine, equipped with the desired reporter moiety (e.g.,
reporter dye; Figure 1E).[70–72] TGase has been applied for in vitro
modification of proteins and was successfully used for EGFR
visualization on live HEK293 cells. Typically, micromolar concen-
trations of the enzyme (~1 μM) and the labeling agent (~
0.5 mM) in the presence of high salt concentrations (e.g.,
12 mM CaCl2) are required for efficient transglutamination.
[72]
Sortase A (SrtA) is an enzyme that catalyzes transpeptida-
tion reactions. To label extracellularly exposed protein N-
termini, the POI is equipped with the LPETG motif, which can
be converted into the poly-glycine-tag by SrtA-mediated trans-
pepdidation using a triglycine probe.[75] In a subsequent second
reaction, the poly-glycine tag is converted by SrtA and addition
of a reporter-LPETG probe. This reaction reconstitutes the initial
LPETG motif at the POI with the addition of the N-terminal
reporter group (e.g., a fluorescent dye). The labeling reaction
involves cleavage of the labeling agent (cargo-LPETGG)
between threonine and glycine and transfer onto the N-
terminal poly-glycine sequence of the POI (Figure 1F).[73–75] In a
typical “sortagging” experiment, 30 μM SrtA and 10 μM labeling
agent was used for labeling of a membrane-anchored cyan FP
(CFP).[75] With only a few recognition features needed, sortase is
an extremely versatile enzyme since labeling can be performed
N- and C-terminally. The reversibility of the reaction and the
need for rather high enzyme loads can be obstacles. However,
an impressive amount of reports provides testimony to the
user-friendliness of sortase methods.[109]
The tubulin tyrosine ligase (TTL) can be applied for protein
labeling at the C terminus, fused to the 14 aa Tub-tag.[79] The
TTL enzyme tolerates various modification of its substrate
tyrosine, which can be equipped with different reactive handles
(e.g., azides) for subsequent two-step labeling as demonstrated
for the GFP-specific nanobody GBP4.[79] Tyrosine transfer by TTL
onto the Tub-tag is performed in 1–3 h, using 1 mM tyrosine
substrate, but requires the supplementation with 2.5 mM ATP
for 1 μM TTL. The reaction time of the subsequent transfer of
the second reporter moiety onto the reactive handle strongly
depends on the applied orthogonal chemistry.[79] However,
labeling of membrane-embedded proteins on live cells by this
methodology is yet to be demonstrated.
2.3. Complementation of reporter units on cell membrane
receptors guided by short peptide tags
Split fluorescent proteins provide the opportunity to express
proteins with a small sized tag and restore fluorescence at
specific time points. For example, the non-fluorescent strands
10 and 11 of GFP act as receptor tag, which reassemble the
native fluorophore upon addition of GFP strands 1–9.[82] In a
typical experiment, fluorescence was induced upon a 20 min
incubation of the N-terminally GFP 10-11-tagged GPCR with
2 μM of GFP 1–9.[82] The split GFP system allows to move the
recognition sequence from the very N terminus into the
extracellular loops (ECL) of GPCRs, increasing the intrinsic assay
flexibility.[110,111] Recently, the splitGFP technique was applied to
other GFP derivatives such as the red fluorescent mCherry.[112]
The tagged GPCR needs to be carefully characterized prior to
protein labeling since the introduction of protein moieties
within the ECL can abolish receptor-ligand interactions.[113,114]
Split luciferases offer an alternative to split FPs. A
particularly noteworthy example involves the nanoLuciferase
(Nluc), which provides brighter chemiluminescence than Renilla
luciferase.[115] The luminophore was split into an 11 aa peptide-
tag (~1.3 kDa, HiBiT) and a cell-impermeable protein fragment
(~18 kDa, LgBiT; Figure 2). Since HiBiT and LgBiT display high
affinity towards each other (KD=0.7 nM), the luminophore is
readily reassembled at low concentration (10 nM) of the LgBiT
agent.[80,116] In a typical assay, LgBiT and furimazine are added to
cells expressing the HiBiT-tagged POI without washing. Lumi-
nescence imaging is performed after 20 min incubation.[81]
Applied to the monitoring of internalization of the adenosine
A1 receptor (A1AR) and β2 adrenergic receptor (β2AR) in live
cells, a decrease of the luminescent signal is observed when
internalized receptors are excluded from interactions with the
cell-impermeable LgBiT.[81,117] Recently, surface-specific labeling
by the HiBiT-LgBiT system was used to study the potential of
the relaxin family receptor-1 (RXFP1) to undergo ligand-induced
homodimerization.[118] The assay was based on the distance-
dependent bioluminescence resonance energy transfer (BRET)
between a luciferase- and mCitrine-tagged RXFP1. Pairs com-
prised of the constitutively active Nluc and mCitrine reporters
showed BRET responses indicative of ligand-independent
formation of RXFP1 dimers. This assay collects signals from
intracellular receptors and surface receptors. By contrast, the
combination of HiBiT-LgBiT and mCitrine reporters provides a
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proximity on the surface is not due to stable interactions but
most likely due to overexpression.
Besides the reconstitution of fluorescent or luminescent
enzymes on membrane-embedded proteins, complementation
platforms have the potential to introduce different reporters on
the POI. The fibronectin-binding protein FbaB from Streptococ-
cus pyogenes, contains a reactive domain, which is capable of
spontaneously forming an isopeptide bond between Lys and
Asp.[83] Howarth and co-worker split the FbaB into two frag-
ments and developed a self-assembling protein labeling
methodology. The SpyTag, a short (13 aa), Asp-containing
peptide, is thereby fused to the POI, reacts with the Lys-
containing SpyCatcher (~15 kDa), forming an amide bond
between the two reactive side chains, and covalently attaching
the SpyCatcher onto the POI.[83] SpyTag-carrying ICAM1 (inter-
cellular adhesion molecule 1) were fluorescently labeled on the
surface of HeLa cells with SpyCatcher, equipped with Alexa
Fluor 555 by incubation with 5 μM SpyCatcher-Alexa Fluor 555
(in PBS, supplemented with 5 mM Mg2+) for 15 min.[83]
2.4. Coiled-coil heterodimers enabling detailed analysis of
membrane protein interactions on live cells
Inducible labeling facilitates real-time monitoring of GPCR or
RTK subpopulations that localize to or pass through the cell
membrane. High rates of labeling are desirable to enable
analyses of fast processes. Peptide-peptide interactions based
on coiled-coil motifs combine high speed of labeling with small
tag size. Coiled-coil motifs are based on heptad repeats,
displaying defined patterns of ionic and hydrophobic residues
on the interaction interface.[119–122] For receptor labeling, one of
the peptide sequences is fused to the N terminus of the POI.
Addition of a suitable “complementary” peptide triggers the
formation of a superhelix comprised of two peptides, which
wrap around each other.[123,124] Labeling the added peptide with
a suitable reporter, for example, a fluorescent organic dye
enables protein visualization upon heterodimerization. A variety
of different coiled-coil peptide pairs have been established for
selective labeling of membrane proteins, ranging from metal-
dependent leucine zippers to artificially generated coiled-coil
motifs (see Table 2 for an overview). Because coiled-coil
sequences can be designed de novo, the heterodimers have the
intrinsic potential to be tailored towards specific
applications.[125] Nanomolar affinities are achieved with �21 aa,
resulting in only minor molecular weights added to the POI (ca.
2–6 kDa). Compared to globular tags such as the reassembled
Nluc and GFP, coiled-coil heterodimers are less bulky, and, thus,
less likely to impair vesicular transport and membrane insertion
of the tagged receptor. Due to the small size, coiled-coil tags
are less likely to interfere with ligand binding to the POI and
lateral protein/protein interactions.
The first coiled-coil system used for receptor imaging was
based on the de novo designed “IAAL” E/K coil system.[126] The E
peptide contains glutamic acid residues on positions “e” and “g”
(Figure 3). In the K peptide, these positions are occupied by
lysine residues. Both peptides have hydrophobic isoleucine at
the “a” position, and leucine at the “d” position. Positions “b”
and “c” are occupied by alanine. The interaction of a 21 aa E3
peptide (=3 heptad repeats) with a 21 aa K3 peptide results in
the formation of a heterodimeric coiled-coil with a stability in
the range of KD ~70 nM.
[126] Extension to four heptad repeats in
the E4 (28 aa)/K4 (28 aa) pair provides even higher stability (KD
~6 nM).[126,127] In their pioneering work, Matsuzaki and co-
workers used the E/K coiled-coils for imaging of a prostaglandin
E2 receptor (EP3βR) and a β2-adrenergic receptor (β2AR) ex-
pressed on living CHO (Chinese hamster ovary) cells.[127] Like in
all other applications of the E3/K3 methodology, the E3-tag was
Figure 2. Reassembly of reporter proteins on GPCR based on small peptide
tags. A) The luciferase Nluc can be reconstituted by an N-terminal peptide
tag (HiBiT, light green) and addition of LgBiT (jade green). The reassembled
enzyme catalyzes the oxidative decarboxylation of furimazine. Formation of
furimamide is accompanied by luminescence. Substrate consumption,
correlates to the number of proteins (gray) on the cell surface. B) To quantify
receptor internalization, control cells and cells treated with agonist are
incubated with LgBiT. The bioluminescence signal is proportional to the
number of reassembled luciferase.
Figure 3. Helix orientation in the parallel E3/K3 heterodimer. Interaction
interfaces of the E3 (sequence: (EIAALEK)3) and K3 (sequence: (KIAALKE)3)
coils are depicted by the hydrophobic interface (jade green); adjacent ionic
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fused to the N terminus of the receptors. For labeling, cells
were incubated with 20–60 nM fluorescence labeled K3 or K4
peptide for 2 min, which were prepared by solid phase peptide
synthesis (SPPS). Using a mixture of two distinct K4 probes
carrying either a tetramethylrhodamine (TAMRA) dye or a pH-
sensitive fluorescein dye enabled a rapid read-out of agonist-
induced uptake of E3-tagged β2AR into endosomes.
[88] Fluores-
cein emission is quenched in acidic compartments leading to
increases of the TAMRA/fluorescein emission ratio when
receptors localize to acidic compartments. It should be noted,
however, that E/K coils are not stable at acidic conditions.
Furthermore, this technique has been applied in nonfluorescent
applications. Nakase, et al. used K4-coated exosomes to cluster
E3-tagged EGFR and induce internalization.[128] Charging K4-
coated exosomes with cell-toxic amounts of saponin allowed
selective killing of E3-POI expressing cells.
An important aspect of the behavior of membrane-
embedded receptors are lateral receptor/receptor interactions
within the lipid bilayer. For example, RTKs form dimers and
various oligomerization modes have been reported for this
protein family.[129,130] To clarify the oligomerization state of the
EGFR in absence and presence of its ligand EGF, Yamashita,
et al. labeled the E3-tagged RTK with a mixture of Alexa568-
and Alexa647-K4 peptides added at defined ratios and
determined the apparent efficiency of fluorescence resonance
energy transfer (FRET) as a function of donor molar fraction[131]
as previously described for the neurokinin-1 receptor labeled by
means of an ACP fusion.[132] Using this approach, it was shown
that the RTK predominantly exists as monomer in the absence
of ligand, whereas agonist addition lead to the formation of
EGFR dimers (Figure 4A). Of note, the investigation revealed
that the EGF concentration required to evoke half-maximal
dimerization is lower than that for half-maximal auto-phosphor-
ylation (Figure 4B).
In light of the controversial discussion about lateral
interactions between GPCRs, Matsuzaki and co-workers inves-
tigated the homodimerization of the CXCR4, the dopamine 2
receptor (D2R) and the prostaglandin E receptor type 1 (EP1R) by
coiled-coil labeling.[133] The dependence of FRET on donor molar
fraction showed that, while no constitutive homodimerization
of the tested GPCRs was detectable, CXCR4 and EP1R clustering
was detectable upon ligand administration. However, the time
Table 2. Coiled-coil interactions established as tag/probe systems for labeling membrane-embedded proteins on live mammalian cells. Core interaction
sequences are given for each tag and probe peptide combination (1-letter code). Additional sequences needed for genetic fusion or bacterial expression are
excluded. Underlined tag/probe sequences have been equipped with reactive moieties for covalent labeling of proteins by different chemistries.
Coiled-coil system Labeling conditions
En/Kn system[87,88,126]
E3-tag EIAALEKEIAALEKEIAALEK Noncovalent labeling: incubation with 20–60 nM
fluorescently labeled K3 or K4 peptide for 2 min.[127]
See also Figure 4.
Covalent labeling: incubation of Cys-E3-tagged POI with
100 nM probe peptide (equipped with cargo through





A2-tag[a] ALKKELEAAKKELEALKKELA-GGCGG-ALEKELEALEKEAEALEKELA Labeling of the A2-tag is performed by applying 1 μM of
the A2 probe for 15 min.[85] See also Figure 5.A2 probe ALKKKLEALKKKXEALKKKLA
CCE/CCK system[84]
CCE3-tag EVAALEKEVAALEKEVAALEK The labeling reaction is performed after a 10 min
incubation with 0.5 mM TCEP (at room temperature)
by administration of 0.2–1 μM peptide probe (reaction
time: 20 min at room temperature).[84] See also Figure 7A.
CCK3 probe KVAALKEKVAALKEKVAALKE
ER3/RCL3 system[138]
ER3-tag EIAALEREIAALEREIAALERGKGSIEGR Covalent labeling is performed by applying 150 nM
fluorescently labeled probe peptide
(reaction time: 10–20 min at 25 °C).[136] See also Figure 7B.
R3CL probe RIAALRERIAALRERIAALREGC
VIP Y/Z[b][86]
CoilY NTVKELKNYIQELEERNAELKNLKEHLKFAKAELEFELAAHKFE After a blocking step with BSA, optimal labeling was
achieved when cells were treated with 300 nM probe for
30 min in buffered cell medium after a BSA blocking step.[86]
CoilZ QKVAQLKNRVAYKLKENAKLENIVARLENDNANLEKDIANLEKDIANLERDVAR
VIPER[b][90]
CoilE LEIEAAFLERENTALETRVAELRQRVQRLRNRVSQYRTR After a blocking step with BSA, labeling was performed
using 100–500 nM peptide probe (reaction time: 15–30 min
at 4 °C).[90] See also Figure 6.
CoilR LEIRAAFLRQRNTALRTEVAELEQEVQRLENEVSQYETR
MiniVIPER[b][91]
MiniE LEIEAAFLERENTALETRVAELRQRVQRLRNE After a blocking step with BSA, labeling was performed




P1-tag EIQALEEENAQLEQENAALEEEIAQLEY Covalent cargo transfer is carried out on in <5 min using
100 nM peptide probe at room temperature.[89]
See also Figure 10.
P2 probe KIAQLKEKNAALKEKNQQLKEKIQALKY
[a] X=2,3-diaminopropionic acid. [b] Core sequences enabling coiled-coil interaction of the tag/probe system. For VIP/VIPER/MiniVIPER both sequences can
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course of FRET emergence was lacking behind the time course
of the ligand-induced Ca2+ influx. The authors hypothesized for
certain GPCRs, that dimerization can lack behind signaling,
suggesting that signaling occurs from receptor monomers
followed by clustering upon ligand-induced internalization
through clathrin-coated pits during the course of internal-
ization. The notion of signaling in a monomeric state contra-
dicts data obtained by bimolecular fluorescence complementa-
tion (BiFC) assays.[134,135] However, measurements of
dimerization by BiFC is arguably less accurate because i)
interaction between split FPs can induce proximity, ii) slow
dissociation kinetics of complemented split FPs perturb equi-
libria and iii) variations of molar ratios of two artificially
expressed proteins is difficult. In contrast, coiled-coil labeling is
reversible, excludes reporter reassembly as driving force of the
POI interaction and allows variations of FRET donor/acceptor
ratios which facilitates quantitative measurements.
Recently, the Jungmann and Seitz groups joined in order to
develop a super resolution microscopy technique which is
based on the reversible formation of E/K coiled-coils.[140] In this
method, transient interactions between a fluorescent molecule
and the POI lead to localized blinking which is the basis for
subdiffraction resolution imaging method known as PAINT (in
points accumulation in nanoscale topography). A systematic
study provided an E/K coiled-coil that is in a dynamic
equilibrium between bound an unbound states. It was shown
that this optimum equilibrium of binding and dissociation was
obtained with an E3 peptide (21 aa) interacting with 18 or 19 aa
K peptides (KD�1.7 μM or 81 nM, respectively). By conjugation
of the modified E3-tag to (secondary) anti-α-tubulin and anti-
vimentin antibodies using DBCO-sulfo-NHS ester chemistry, the
intricate cellular cytoskeleton could be visualized by super-
resolution microscopy. Imaging speed and efficiency of PAINT
enabled by the E/K coiled-coil interaction outperformed the
previously reported DNA PAINT method.
The Tamamura group developed a fluorogenic labeling
method, which relies on the formation of trimeric coiled-coil.
Two α-helical peptides derived from the GCN4 leucine zipper
were linked through a 5 aa loop. The 47 aa construct (A2-tag)
was genetically fused to the N terminus of the GPCR CXCR4. A
23 aa probe peptide (A2-peptide) was labeled with a 4-nitro-
benzenzo-2-oxa-1,3-diazole (NBD) dye, which is positioned
within a hydrophobic environment upon formation of the 70 aa
tag/probe complex (Figure 5).[85] A wavelength shift and
enhancements of fluorescence enables a wash-free imaging. In
the pursuit of a heterodimeric pair combining high affinity with
a balance of basic and acidic residues within each strand, Beatty
and co-workers introduced the VIP (versatile interacting pep-
tide) tag.[86] This system consists of two genetically encoded
peptide tags: CoilY and CoilZ, derived from synthetic hetero-
dimeric coiled-coils (SYNZIP).[141] Both sequences can be used as
protein tag or peptide probe respectively (CoilY-tag/CoilZ probe
and CoilZ-tag/CoilY probe). To establish labeling by the VIP
system, the 44 aa tags were fused to membrane-anchored
fluorescent proteins GFP and mCherry. The 69 aa labeling
probes were generated by bacterial expression and equipped
with the fluorescent reporter or a biotin moiety through a
cysteine residue. For protein labeling in live cells, a blocking
step with high concentration of BSA (6%, w/v) was applied
prior to incubation of probes. Optimal labeling was achieved
when cells were treated with 300 nM probe for 30 min in
buffered cell medium.[86]
The Beatty lab also introduced the VIPER system, which is
comprised of the 43 aa CoilE tag and the 69 aa CoilR tag and
involves the formation of a very stable coiled-coil (KD=
13 pM).[90] The system was applied (Figure 6) to investigate the
internalization of the transferrin receptor 1 (TfR1) protein
complex in transfected CHO cells by using quantum dots as
Figure 4. Application of N-terminal protein labeling by coiled-coil interaction
to investigate EGFR dimerization on the surface of live cells. A) Heteromeric
coiled-coil interactions enable competitive labeling of E3-tagged GPCR (light
green) by using K4 donor probes (jade green) with two FRET-compatible
dyes (red/green stars). In the absence of ligand, EGFRs remain as monomers
on the cell surface. B) Addition of EGF (yellow) induces E3-EGFR dimerization,
triggering the FRET between the two Using FRET as readout revealed that
EGFR dimerization occurs prior to EGFR cross-phosphorylation (left). FRET
data derived from Yamashita, et al.[131]
Figure 5. GPCR labeling on cell surfaces by using trimeric coiled-coils. Two
α-helical peptides (A2-tag, light green), linked by a short loop, are genetically
fused to the N terminus of the CXC-motif chemokine receptor 4(CXCR4,
gray). The A2 peptide probe is equipped with 4-nitrobenzenzo-2-oxa-1,3-
diazole (NBD, yellow). Upon formation of a tag-probe complex, NBD is
positioned within a hydrophobic environment, inducing fluorescence
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reporter groups for electron microscopy. Labeling succeeded
within 15 min. The method enables correlated light-electron
microscopy (CLEM) imaging. Of further notice is the application
of VIPER to intracellular targets.[142] The CoilE-acceptor peptide
was genetically fused to the histone protein H2B, whereas the
CoilR probe was delivered to the POI by using nanoshells
equipped with cell-penetrating peptides. Very recently, Beatty
and co-workers reduced the size of their coiled-coil sequences
and introduced the 32 aa MiniE and MiniR tags, which are
recognized by 64 aa MiniR and MiniE probes.[91]
Labeling by formation of coiled-coils is reversible. Large
coiled-coils provide very high stability. The size of ultrastable
coiled-coil tags such as the VIPER-tag (�13 kDa) still compares
favorably with that of enzyme-based tags such as the SNAP-tag
(20 kDa). Smaller tags such as the E3/K3 tag add less molecular
weight and SPPS provides facile access to various functionalized
labeling probes given the peptides are short. However, with
short coiled-coils dissociation may occur at dilution conditions
after prolonged times and under acidic conditions within
endosomal compartments.
Coiled-coil guided conjugation reactions offer the prospect
of combining high stability of labeling with small tag size. Xia
and co-workers developed a method for the proximity-induced
covalent labeling upon formation of an E3/K3 coiled-coil
derivative (CCE3/CCK3 system) featuring valine instead of
isoleucine.[84] The reaction involved a cysteine residue at an
internal position of the CCE3-tag and a chloroacetyl group that
was connected to the “side chain” of 2,3-diaminopropanoic acid
of a CCK3 peptide derived labeling probe (Figure 7A). For
labeling, CHO cells expressing the CCE3-tagged POI were
incubated for >20 min with a bidentate, 53 aa reactive CCK3
peptide in 0.2–1 μM concentration. Yano, et al. reported on a
covalent cargo transfer method based on the free N-terminal
amino function of the E3-tagged POI.[138] The R3CL3 peptide
probe was C-terminally armed with a sulfosuccinimidyl ester.
For this purpose, a cysteine side chain was modified in a
reaction with a maleimide-based bifunctional reagent. Forma-
tion of the coiled-coil brings the reactive moiety into close
proximity of a lysine side chain near the C terminus of the ER3-
tag. This covalently crosslinks the R3CL probe with the ER3-tag,
yielding a 5.5–6 kDa label (Figure 7B). For efficient labeling,
CHO cells expressing ER3-tagged β2AR were incubated with
150 nM probe for 2×10 min. In contrast to experiments with
unreactive coiled-coils, the label remained after 5 washes with
PBS, indicating the stability provided by covalent bonds. Within
the context of work funded by the Deutsche Forschungsge-
meinschaft (DFG) Priority Program SPP1623 (BE1264-15) we
aimed for a labeling method that provided for very high
reaction rates at small tags. To achieve this aim, we repurposed
the E3/K3 system for covalent labeling by a proximity-triggered
acyl transfer reaction.[87,137] The E3-tag was elongated by an
additional cysteine residue at its N terminus (Cys-E3-tag). This
cysteine served as an acceptor of the reporter group. To enable
fast labeling by native chemical ligation (NCL)-type
reactions,[143,144] the reporter group was linked as a thioester to a
mercaptoaryl group mounted at the N terminus of the K3
peptide probe (Figure 7C). The end-of-helix arrangement brings
the reactive groups into very close proximity, and coiled-coil-
induced label transfer proceeded with t1=2 =1–2 min. Of note,
the reaction does not ligate the E3-tag with the K3 probe and
the overall label size remains small (�3 kDa). A typical labeling
Figure 6. Labeling of membrane proteins by using the VIPER system. A) The
transferrin receptor 1 (TfR1, gray) is fused to the CoilE-tag. B) Administration
of the CoilR probe, equipped with an AF488 fluorophore (red star) enables
visualization of the POI and live cell experiments. C) The CoilR can be
equipped with a biotin group (yellow) to label the protein. Upon cell
fixation, the biotin label is addressed by a streptavidin probe (SA, purple)
quarrying a quantum dot (Qdot, light pink), allowing electron microscopy.
Figure 7. Covalent protein labeling at the protein mediated by coiled-coil
peptide heterodimers. A protein of interest (POI, grey box) tagged with a
peptide recognition tag (green) at the N terminus is selectively labeled with
a cargo (red star) by means of a proximity-triggered reaction. Covalent
protein labeling is achieved by chloroacetyl crosslinking (A), sulfosuccinimid-
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reaction involves 100 nM K3 conjugate and is performed for
5 min only. Using this peptide-templated NCL, several pharma-
cologically interesting GPCRs like the human neuropeptide Y
receptor type 1, 2, 4, and 5 (hY1/2/4/5R), the neuropeptide FF
receptors 1 and 2 (NPFF1/2R), and the dopamine receptor 1 (D1R)
were efficiently visualized in live cell experiments, circum-
venting the need for C-terminal auto-fluorescent proteins
(Figure 8).[87] We showed that efficient labeling with the
fluorophore TAMRA, attached to the K3 peptide, was only
observable for HEK293 cells expressing the respective receptor.
No off-target signals were detected, highlighting the selectivity
of the peptide-templated NCL-type reaction. As expected, the
label withstands mild acidic (pH 5) and mild basic (pH 9)
conditions, which would not be possible with labels installed by
noncovalent coiled-coils. As a result, the label persists the
passage through endosomal compartments when tagged
receptors internalize upon stimulation with agonist and recycle
to the membrane. The high speed of labeling by the peptide-
templated acyl transfer is advantageous for investigations of
short-lived cellular processes. Furthermore, the stability pro-
vided by covalently attached labels facilitates long-term pulse-
chase experiments and circumvents the need for auto-fluores-
cent proteins fused to the POI. In an exemplary study, we
examined intracellular sorting of internalized hY2R by two color
pulse-chase labeling in live mammalian cells (Figure 9).[136] Prior
to agonist-mediated internalization, the Cys-E3-hY2R was pulse
labeled by means of a 3 min incubation with 150 nM TAMRA-
armed K3 conjugate. Chase labeling of membrane-retained Y2R
subpopulations was performed using a green Atto488-carrying
donor probe. This enabled the intracellular tracking of internal-
ized hY2R subpopulations by multi-color visualization with high
spatial and temporal resolution due to the short labeling
protocol. It was shown that hY2R populations, which have been
internalized at different time points, are not trafficked sepa-
rately but instead are pooled within minutes in early or sorting
endosomes. Recently, Gavins, et al. reported on a novel coiled-
coil labeling system which enables the erasable imaging of
GPCRs and RTKs (Figure 10A).[89] The method relies on the 28 aa
P1 and P2 coiled-coil peptides introduced by Jerala.[139] An N-
terminal Cys-P1-tag was fused to the human EGFR, and the
endothelin B receptor (ETBR), a rhodopsin-like GPCR and labeled
upon incubation with a “complementary” peptide probe P2.
The labeling reaction installed a peptide nucleic acid (PNA)
strand which was transferred from the thioester linked PNA-P2
conjugate to Cys-P1-POI. Like the E3/K3 system, the covalent
transfer of the cargo relies on a proximity-triggered NCL and
can be carried out on different mammalian cell lines (HEK293
and CHO) in less than 5 min using low probe concentrations
(e.g., 100 nM PNA-MPAA-P2). Once the POI is equipped with
Figure 8. Peptide-templated labeling of N-terminally Cys-E3-tagged G pro-
tein-coupled receptors (GPCR) and its application to live cell imaging.
Labeling was performed on GPCRs carrying a C-terminal eYFP (enhanced
yellow fluorescent protein) in transient transfected HEK293 cells. N-terminal
fusion of the Cys-E3-tag was performed to the human receptors neuro-
peptide Y receptor 1 and 4 (hY1/4R), the neuropeptide FF receptor 1 and 2
(hNPFF1/2R), and the dopamine receptor 1 (hD1R). Microscopy data adapted
from Reinhardt, et al.[87]
Figure 9. Investigation of distinct human neuropeptide Y receptor 2 (hY2R)
subpopulations by pulse-chase labeling. Cys-E3-tagged hY2R were pulse
labeled (red) by peptide-templated NCL prior to agonist-induced internal-
ization. After the first stimulation, the remaining Cys-E3-hY2R, residing in the
cell membrane, were chase labeled (light green) by peptide-templated NCL.
Chase-labeled receptors were internalized upon agonist addition and co-
localized with chase-labeled hY2R populations after >10 min (fused vesicles
indicated by white arrows). Fusion of pulse- and chase-labeled vesicles
shown by (merged) yellow structures in the overlay pictures. Data adapted
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the PNA cargo, the PNA label subsequently serves as barcode
for the hybridization with fluorescence labeled complementary
DNA, which is complete upon <5 min incubation with 200 nM
DNA probe. Labeling of human EGFR in live cells with organic
dyes like TAMRA, Cy3, Cy7, and Atto565 demonstrated the high
versatility offered by the modularity of the approach and the
commercial availability of dye-labeled oligonucleotides. The
method provides a convenient way to increase the brightness
of labels. For this purpose, the PNA tag is hybridized with a
sticky end DNA complex prepared by alignment of multiple
fluorescent DNA strands along a DNA adaptor strand. An
interesting aspect of the PNA barcoding approach is the
removal of hybridized fluorescent DNA by toehold-mediated
strand displacement, allowing erasure of the fluorescent signals
from the cell membrane (Figure 10B). This is especially interest-
ing for GPCRs and RTKs with only minor internalization rates. In
this case, internalized subpopulations can be tracked without
noise from membrane-residing POI after incomplete receptor
internalization.
Recently, Jerala introduced a set of six orthogonal coiled-
coil pairs. In a noteworthy application, three coiled-coil pairs
were used to equip fluorescent proteins with localizers based
on nuclear localization sequences, nuclear export signals or a
membrane localization protein.[145] Beatty combined two coiled-
coils, the MiniVIPER and the VIPER systems, for orthogonal
noncovalent labeling of transferrin receptor TfR1 and histon
protein H2B as examples for two distinct protein targets.[91]
2.5. Recognition of small amino acid tags by (semi)-metals
A very small size is the characteristic feature of the self-labeling
tetracysteine motif (CCXXCC; X=A, G, or P). Covalent labeling
of this motif is achieved by fluorescein arsenical helix binder
(FlAsH), containing two arsonous acid thioester centers (Fig-
ure 11A).[146] The typically used FlAsH derivatives provide
fluorescence enhancement upon binding to the tetracysteine
motif. For extracellular labeling, cells expressing the tagged
protein need to be pre-incubated with reducing agents (e.g.,
5 mM 2-(N-morpholino)ethanesulfonic acid (MES) and 0.5 mM
TCEP in HBSS for 20–30 min) to ensure that free thiols are
accessible for on surface labeling prior to addition of the
labeling reactant.[92] Subsequent labeling involves 2–5 μM
concentrations of the arsenic FlAsH for efficient tag
conversion.[92] Despite reports about background signals and
off-target labeling[147–149] FlAsH tagging has been widely applied
to study GPCR interactions e.g. by determination of pure
rotational diffusion of the β2aAR on live cells.
[93] For an
alternative to FlAsH, the cysteine residues were substituted by
serine residues (tetraserine motif; SSXXSS; X=A, G, or P), which
enable recognition by less toxic bisboronic acid probes.[150]
However, the abundancy of polyserine-containing proteins
causes a high background.
Selective ion chelation is commonly used in protein
purification, for example, for immobilizing oligo-His-tagged
proteins on substrates containing N-nitrilotriacetic acid (NTA)
complexes of Co2+, Ni2+, or Zn2+.[151,152] This approach has been
repurposed to live cellfluorescence imaging (Figure 11B).[153]
NTA was equipped with an organic fluorophore and used to
label N-terminally oligo-His-tagged platelet derived growth
factor (PDGF) receptor.[96] Visualization can be performed in
<15 min, using only 15 nM of dye-conjugated, Ni2+-loaded
NTA. The affinity of the His-stretch for the metal ion correlates
with the length of the oligo-His sequence. His10 displays a
sixfold higher Ni2+affinity than the shorter His6-tag (KD~166 nM
and 1.05 μM, respectively).[94] The binding of NTA-chelated Ni2+
to histidine involves two distinct coordination sites, able to
recognize separate imidazole moieties with a binding affinity of
approximately ~10 μM.[154,155] The remaining four coordination
sites of the cation are occupied by the chelating NTA.[155]
Figure 10. Labeling of membrane proteins by coiled-coil-templated barcod-
ing with peptide nucleic acid (PNA). A) The POI (gray) was N-terminally fused
to the peptide tag Cys-P1-tag (light green). Addition of peptide probe P2
(jade green) triggers a coiled-coil-induced labeling reaction that installs a
PNA tag. The PNA-Cys-P1-POI is fluorescently labeled by hybridization with a
complementary oligonucleotide (light brown bar) equipped with a fluores-
cent dye (red star). Brightness-enhanced labeling of PNA-Cys-P1-POI is
achieved by hybridization with an elongated DNA strand, allowing multiple
hybridization steps with smaller fluorescently labeled oligonucleotides (light
red bar). Using toehold-mediated strand displacement, the fluorescence is
erased from the PNA by displacing the small fluorescent DNA fragments
with complementary DNA sequences (dark red bar). B) EGFR was labeled
with Atto565 by coiled-coil-induced PNA barcoding and DNA hybridization,
and subsequently treated with EGF. It is difficult to detect internalized EGFR
behind the background of EGFRs on the membrane (upper row). Internalized
receptors are visualized with higher signal-to-noise ratios upon toehold-
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Simultaneous binding of multiple Ni-NTA units to multiple
imidazole groups along a His6-tag boosts the binding affinity as
shown for different NTAs binding to oligo-His6-tags: mono-NTA
(KD~13 μM)<bis-NTA (KD~68 nM)< tris-NTA (KD~2.1 nM).
[154]
The graded affinity of tris-NTA probes for His6-and His10-tags
enabled imaging of intracellular His10-tagged POIs by complex-
ation with His6-tagged cell penetrating peptides.
[156,157]
For covalent POI modification, a chloroalkane NTA entity
was developed. The method allowed imaging of the GPCR B2R
on live mammalian cells.[95,158] To facilitate crosslinking of the
NTA with the POI a cysteine residue was added at the
N terminus of the His-tag (Cys-His6-tag). As shown for the
bradykinin N2 receptor (B2R), a pre-incubation with 0.5 mM
TCEP was required prior to addition of 0.5 μM labeling probe.
Efficient GPCR labeling was performed in less than 30 min. In
addition to histidine-mediated ion chelation, aspartate repeats
can be applied for protein labeling as well. Several oligo-
aspartate-tags are described (D3, D4, D4x2) to fine tune the
affinity of Zn2+-loaded probes, which have been successfully
applied for N-terminal labeling of the B2R and muscarinic
acetylcholine receptor M1 using protocols, comparable to oligo-
His-tag labeling.[159–161] Similar to the oligo-His-tags, oligo-Asp-
mediated labeling is reversible due to the transient interaction
with the metal ion, but can be converted into covalent POI
modification by introducing a chloroalkane moiety into the
metal loaded NTA and adding an N-terminal cysteine residue
into the oligo-Asp-tag.[158]
2.6. Special case: Traceless labeling by split-intein-mediated
splicing
Despite small tag sizes, all of the aforementioned labeling
platforms induce modifications of the endogenous protein
sequence to generate reaction specificity. Ideally, protein label-
ing technologies do not alter or add to the POI sequence. This
can be achieved by split intein-mediated protein trans-splicing
(PTS) since the intein is removed from the POI during the
ligation of the flanking exteins.[162] PTS is commonly applied to
protein semi-synthesis and modification.[163–166] For split intein-
based techniques, one fragment is synthetically generated and
equipped with the reporter, whereas the complementary frag-
ment is fused to the POI (Figure 12). Different split-intein
platforms have been developed based on natural occurring
systems. The split α-subunit of the DNA polymerase III (DnaE),
derived from Nostoc punctiforme (Npu)[167] and Anabaena
variabilis (Ava),[168] are amongst the most common split-intein
PTS platforms applied to protein labeling in cellular
contexts.[169–171] High-affinity inteins have been developed as
demonstrated for the engineering of the split DnaB M86 mini-
intein system (Ssp DnaB M86), which displays a 10 nM fragment
affinity.[172] For modification of proteins embedded in cell
membranes, C-terminal labeling was demonstrated for the TfR1
in CHO cells.[173] The C terminus of TfR1 was fused to the 150 aa
N-intein of the noncanonical split-intein Ssp GyrB S11. The
synthetic 6 aa short C-intein was equipped with fluorescein for
covalent labeling. PTS was efficient after 18 h incubation with
micromolar C-intein concentrations (1.25–12.5 μM). N-terminal
protein labeling on live cells was demonstrated for the red
fluorescent protein (mRFP), anchored in the membrane of CHO
cells.[98] The DnaBC(12–154) fragment (C-intein) was fused to
mRFP and labeled with 0.5 μM of the respective N-intein,
equipped with biotin, requiring 20 mM reduced glutathione
and a reaction time of 8 h. Subsequent POI visualization was
performed by anti-biotin staining using fluorescent streptavidin.
Figure 11. Labeling of membrane proteins such as GPCRs by metal ions
recognizing small amino acid tags on live cells. A) A tetracysteine fragment
(CCXXCC; X=A, G, or P; green) is genetically fused to the N terminus of a
GPCR (gray). Addition of FlAsH (fluorescein arsenical hairpin binder) transfers
the bisarsenic fluorescein onto the free thiols of the cysteine stretch, thus
enhancing the fluorescence of the dye. B) The His6-tag (green), fused to the
N terminus of a membrane protein like a GPCR (gray), can be labeled with
Ni2+-loaded tris-NTA (N-nitrilotriacetic acid). The metal ion is selectively
chelated by clustered imidazole side chains of the oligo-histidine sequence.
To visualize the POI, the tris-NTA is equipped with a respective reporter
moiety like an organic dye.
Figure 12. Reaction scheme of split-intein-mediated trans-splicing (PTS) of
protein N termini. For split-intein-based techniques applied to the protein
N terminus, the C-terminal fragment (C-Int, purple) is fused to the target
protein (POI, gray), while the N-terminal fragment (N-Int, yellow) is artificially
generated to carry the required reporter unit (green with red star). Split-
intein-mediated PTS is a traceless labeling approach as the intein fragments
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Recently, Mootz and co-workers reported on the Gp41-1 split
intein and in cellulo semisynthesis of intracellular proteins in
live mammalian cells using relatively short peptide fragments
(N-intein: 88 aa, C-intein: 37 aa).[97] This split intein displays rapid
PTS (t1/2~5 s at 37 °C) with high yields.
[174,175] However, split
intein approaches are still limited to rather big POI modifica-
tions for efficient labeling, when targeting the N terminus of
proteins like GPCRs and RTKs.[176,177] Despite the big POI
modification, the reaction occurs traceless and removes the
recognition site at the POI.[178]
3. Summary and Outlook
Our overview of the methods available for labeling of cell
surface receptors points to a remarkable development. Early
research had to rely on fusion of the POI with a fluorescent
protein. More than two decades ago, Tsien, et al. introduced the
FlAsH method which allowed labeling by short peptide tags.[146]
After their seminal contribution, the field took off in the 2000s
with a series of papers from the Johnsson, Ting and Ploegh
groups on exploiting enzymes for protein labeling.[73,101,179] Using
phosphopantetheinyl transferases (AcpS, Sfp), biotin ligase
(BirA) and lipoic acid ligase (LplA) to transfer reporter groups
from a donor substrate to specific peptide sequences was also
based on genetically encodable tags. However, even after
labeling the peptide tags are much smaller than fluorescent or
bioluminescent fusion proteins. Furthermore, the reagents can
be tailored to exclude intracellular protein populations from
labeling. Enzyme-based techniques facilitate the analysis of cell
surface expression and internalization of receptors, and allow
orthogonal labeling. However, substrates are often added in
high concentration, co-factors may be required, and the
enzyme’s specificity frequently limits the choice of the reporter
group. In this case, bioorthogonal chemistries provide remedy
by allowing secondary labeling of modified conjugates in a
two-step protocol. In the pursuit of highly efficient labeling
methods, the self-modifying SNAP- and Halo-tags were devel-
oped. Surface-specific labeling requires cell-impermeable label-
ing agents.[180,181] In general, the size of the enzyme tags is a
concern in investigating proximity-dependent protein interac-
tions. Complementation methods, in which short peptide tags
guide the assembly of a fluorescent or luminescent protein also
provide for robust labeling. The cargo added to the POI remains
small prior to labeling, however, the size issue resurfaces after
labeling.
Aiming for small tag sizes similar to peptide tags used for
enzymatic labeling, but enabling labeling at much higher
speed, Matsuzaki introduced the coiled-coil labeling system.[127]
With this method labeling succeeds on small tags (2–3 kDa for
each tag and labeling probe) at nanomolar concentration
within less than 5 min without extensive washing protocols.
The method has proven valuable for the analysis of GPCR
homodimerization by FRET measurements.[133] Contributions of
the Tamamura and Beatty labs on fluorogenic labeling and
stability-improved coiled-coils, showcased the versatility of the
coiled-coil method.[85,86,91,142] The adjustability of coiled-coil
interactions allowed the development of peptide PAINT for
subdiffraction resolution imaging.[140] Seeking to combine both
stability and speed of labeling, coiled-coil interactions have
been used to template proximity-triggered chemical reactions.
For example, acyl reporter groups can be transferred from
thioester-linked peptide probes onto cysteinyl peptide tags
within 2–5 minutes.[87,136] An extension of the method enabled
tagging of receptor proteins with PNA, which can serve as a
universal landing hub for functional units through oligonucleo-
tide hybridization. We have shown that erasable fluorescence
labeling by toehold-mediated displacement of oligonucleotide-
dye conjugates facilitated the analysis of EGFR internalization.[89]
Focusing on the application of known fusion proteins, metal
ion recognition tags based on the interaction between oligo-
histidine tags and NiII·trisNTA complexes are noteworthy
contributions due to their tunable affinity based on the oligo-
histidine length.[154]
The intein technology approaches an ideal labeling method-
ology, because the tag is excised upon labeling. For C-terminal
labeling, the short C-terminal intein fragment carries the
fluorophore and a bigger N-terminal fragments is fused to the
POI.N-terminal labelling calls for fluorescence labelled N-intein
agents, which are – given their size – more difficult to prepare.
The breadth of methods allowing a cell surface specific
labeling of receptor proteins is extremely useful for GPCR and
RTK research. These receptors are amongst the most frequently
addressed targets in medicinal chemistry, pharmacology and
cell biology. Typical research questions refer to localization,
internalization, trafficking, interaction partners and oligomeriza-
tion of the receptors, preferably within their native environ-
ment. Fluorescence microscopy and the methods described in
this review can provide answers to these questions.
In future research, multiplexed labeling will likely be
important to study interactions/trafficking of a set of receptors.
In this regard, a combination of orthogonal labeling methods
will be needed as demonstrated by Jerala[145] and Beatty[91] labs
using coiled-coil heterodimers. Protein-protein interactions
need to be studied under native conditions – ideally, in tissues
or in vivo models. Using gene editing tools like CRISPR/Cas9, it
was already demonstrated that short tags can be used for POI
labeling under native expression levels in cell culture models.[116]
Additionally, efficient in vivo labeling requires cargos like
quantum dots,[182,183] to reduce tissue-derived noise. A major
obstacle is the delivery of the labeling probe to the desired
tissue, which is limiting to labeling platforms requiring huge
probes with impaired tissue penetration properties.[184] There-
fore, we should focus on methods that enable a free choice of
labels to allow the introduction of superbright fluorophores
with extreme selectivity. We believe that coiled-coil platforms
provide a suitable mix of properties. We also foresee an
increasing importance for inducible labeling systems enabling
the monitoring or even manipulation of receptor properties. For
example, methods allowing an inducible homo- or heterodime-
rization by small tags are expected to shine light on the
significance of receptor oligomerization and cross activation.
This calls for modular methods that allow facile variations of the
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now and the authors of this review article are confident that
new imaging modalities and applications will emerge soon.
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